Clover Corporation Limited advises of planned succession changes to the Board of Directors. Dr. Merilyn Sleigh and Ms. Cheryl Hayman who have been Non-Executive Directors for the past 12 years are standing down from the Board. Merilyn has resigned effective October 20, 2020 and Cheryl who is due to retire at the Company's upcoming annual general meeting has decided not to stand for re-election. The company announced the appointment of two Non-Executive Directors effective October 20, 2020 - Ms. Toni Brendish and Dr. Simon Green. Toni has more than 30 years' experience, including over 20 years in CEO or Managing Director roles, predominantly working for blue chip fast-moving consumer goods, services and telecommunication companies. She has extensive experience in manufacturing, supply chain and regulatory management of infant formula markets across Asia, Australia, New Zealand, China and Europe. Simon has 30 years of experience in the biotechnology industry focused on the discovery, development and commercialisation of life saving medicines. He was actively involved in CSL's global expansion and held roles as Senior Vice President in R&D and manufacturing operations.